A review of cancer immunotherapy: from the past, to the present, to the future Page 1 S87
Current Oncology, Vol. 27, Supp. 2, April 2020 © 2020 Multimed Inc. REVIEW ARTICLE A …

Studies on the role of gut commensal bacteria in health development have rapidly attracted
much more attention beyond the classical pathogens over the last decade. Many important …

The performance of immune-checkpoint inhibitors, which benefit only a subset of patients
and can cause serious immune-related adverse events, underscores the need for strategies …

Highlights•A melanoma consensus conference, organised by the ESMO Guidelines
Committee, was attended by 32 experts from 14 countries•The experts compiled …

Immune checkpoint inhibitors (ICIs), as one of the innovative types of immunotherapies,
including programmed cell death-1 (PD-1), programmed cell death-ligand 1 (PD-L1), and …

Background With the advent of immunotherapy, substantial progress has been made in
improving outcomes for patients with advanced cancer. However, not all patients benefit …

Peptide-based anticancer vaccination aims at stimulating an immune response against one
or multiple tumor-associated antigens (TAAs) following immunization with purified …

The immune system plays a key role in cancer suppression. Immunotherapy is widely used
as a treatment method in patients with various types of cancer. Immune checkpoint blockade …

Human gut microbiome is a major source of human bacterial population and a significant
contribution to both positive and harmful effects. Due to its involvement in a variety of …

Cancer displays high levels of heterogeneity and mutation potential, and curing cancer
remains a challenge that clinicians and researchers are eager to overcome. In recent years …